Liquid Biopsies to support Cancer Patient Treatment Management

Healthy Lives


15:30 - 16:00

ctDNA analyses are increasingly considered for cancer patient management, for prognosis, stratification, treatment response monitoring and detecting minimal residual disease.  Professor Dive will discuss several examples including selection of Phase I trials with ctDNA. 

Circulating tumour cell (CTC) analysis is technically challenging but can teach us about the biology of dissemination, tumour evolution and metastasis. Professor Dive will discuss several examples, including the generation of mouse models of small cell lung cancer derived from patients CTCs.

Multimodal liquid biopsies are likely to be needed for earlier detection of cancers. Professor Dive will discuss the challenges that lie ahead focusing on lung cancer.


Caroline Dive

Cancer Research UK, Manchester Institute
The University of Manchester

After completi...